The HPV Vaccine On Trial: Seeking Justice For A Generation BetrayedA Groundbreaking Guide to the HPV Vaccine and the Science, Safety, and Business Behind It Cancer strikes fear in people’s hearts around globe. So the appearance of a vaccine to prevent cancer–as we are assured the human papillomavirus (HPV) vaccine will–seemed like a game-changer. Since 2006, over eighty countries have approved the vaccine, with glowing endorsements from the world’s foremost medical authorities. Bringing in over $2.5 billion in annual sales, the HPV vaccine is a pharmaceutical juggernaut. Yet scandal now engulfs it worldwide. The HPV Vaccine on Trial is a shocking tale, chronicling the global efforts to sell and compel this alleged miracle. The book opens with the vaccine’s invention, winds through its regulatory labyrinths, details the crushing denial and dismissal of reported harms and deaths, and uncovers the enormous profits pharma and inventors have reaped. Authors Holland, Mack Rosenberg, and Iorio drill down into the clinical trial data, government approvals, advertising, and personal accounts of egregious injuries that have followed in countries as far-flung as Japan, Australia, Colombia, India, Ireland, the U.K. and Denmark. The authors have written an unprecedented exposé about this vaunted vaccine. Written in plain language, the book is for everyone concerned – parents, patients, doctors, nurses, scientists, healthcare organizations, government officials, and schools. Ultimately, this book is not just about the HPV vaccine, but about how industry, government, and medical authorities may be putting the world’s children in harm’s way. |
Contents
Racing toward the Vaccine | |
Whos Really At Risk for Cervical Cancer? | |
Clinical Trials The Foundation for the HPV Vaccine | |
Seeking Justice | |
Controlling the Message | |
Australia First to Inject | |
A DEEPER LOOK AT HPV VACCINE SCIENCE | |
Challenging the Scientific Consensus The Mavericks | |
AluminumContaining Adjuvants Fueling the Fire? | |
What Else Is in the Vial? | |
HPV Vaccines Autoimmunity and Molecular Mimicry | |
Rushing Results Surrogate Endpoints and FastTracking | |
Fauxcebos and Placebos | |
Protocol 018 Hiding in Plain Sight? | |
Enhancing Risk Negative Efficacy | |
Fertility EffectsTrial Signals Missed? | |
Clinical Trial Malfeasance | |
India A Clinical Trial Scandal | |
THE HPV VACCINE HITS THE MARKET | |
A Market out of Thin | |
The United States Selling and Compelling | |
Injury Reports Flood | |
The Overlooked Fallout from the HPV Vaccine | |
THE ASCENT OF DISSENT | |
Japan Pulling the Plug | |
Denmark Pushing Back in Europe | |
Ireland Injected and Neglected | |
The United Kingdom Media Magic | |
Colombia Families Fighting Back | |
The Emperor Has No Clothes | |
Endnotes Index About the Authors | |
Common terms and phrases
AAHS adjuvants adverse events Agency aluminum American appears approved asked associated authors autoimmune called cause cells Cervarix cervical cancer Chapter claims clinical trials Committee compensation concerns consent continued countries Court critical daughter death Despite disease doctors dose drug effects Emily et al evidence experts families filed further Gardasil 9 girls HPV vaccine Human Papillomavirus Ibid immune infection issue Japan Journal look manufacturers March Medicine meeting Merck months never parents percent placebo possible potential prevent protect Protocol published questions rates reactions received recommended response risk safe safety saline scientific scientists screening serious side story suggests symptoms tests University vaccine injury women young